Back to XENE
MARSHALL WACE, LLP XENE Position History
Xenon Pharmaceuticals Inc. • Healthcare
Quarters held
20
Latest value
$41.5M
Q2 2026
Peak value
$89.1M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $191K |
| Q1 2023 | $82.9M |
| Q2 2023 | $194K |
| Q2 2023 | $89.1M |
| Q3 2023 | $193K |
| Q3 2023 | $73.4M |
| Q4 2023 | $70.4M |
| Q1 2024 | $62.4M |
| Q2 2024 | $23K |
| Q2 2024 | $54M |
| Q3 2024 | $47.1M |
| Q4 2024 | $35.3M |
| Q1 2025 | $2.8M |
| Q1 2025 | $22.6M |
| Q2 2025 | $31.9M |
| Q3 2025 | $24.6M |
| Q4 2025 | $136K |
| Q4 2025 | $7.2M |
| Q2 2026 | $146K |
| Q2 2026 | $41.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $41.5M | 686.9K | — | — |
| Q2 2026 | $146K | 2.4K | — | — |
| Q4 2025 | $7.2M | 159.5K | — | — |
| Q4 2025 | $136K | 3.0K | — | — |
| Q3 2025 | $24.6M | 612.0K | — | — |
| Q2 2025 | $31.9M | 1.02M | — | — |
| Q1 2025 | $22.6M | 674.9K | — | — |
| Q1 2025 | $2.8M | 83.2K | — | — |
| Q4 2024 | $35.3M | 899.7K | — | — |
| Q3 2024 | $47.1M | 1.20M | — | — |
| Q2 2024 | $54M | 1.38M | — | — |
| Q2 2024 | $23K | 600 | — | — |
| Q1 2024 | $62.4M | 1.45M | — | — |
| Q4 2023 | $70.4M | 1.53M | — | — |
| Q3 2023 | $73.4M | 2.15M | — | — |
| Q3 2023 | $193K | 5.6K | — | — |
| Q2 2023 | $89.1M | 2.32M | — | — |
| Q2 2023 | $194K | 5.0K | — | — |
| Q1 2023 | $82.9M | 2.32M | — | — |
| Q1 2023 | $191K | 5.3K | — | — |
Other funds holding XENE
$143.4M
$136.9M
$118.9M
$118.9M
$100M